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I. Introduction
The development and causes of inflammatory bowel diseases (IBD) are extensively affected by genetic susceptibility, intestinal microbiota, environmental factors, and host immune dysregulation, all of which are interrelated [3, 21] . However, the exact etiology and pathogenesis of IBD remains unclear. The clinical features of the two major forms of IBD, ulcerative colitis (UC) and Crohn's disease, differ to some extent [16] , but both exhibit inappropriate Correspondence to: Atsushi Nanashima, Department of Surgery, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan. E-mail: a_nanashima@med.miyazaki-u.ac.jp and ongoing activation of the mucosal immune system [21] . T lymphocytes play an important role in the production of proinflammatory cytokines and in immunoregulatory function.
CD161 encoded by KLRB1 (human killer cell lectinlike receptor subfamily B, member 1) is a C-type lectin-like receptor that exhibits both activating and inhibitory function in natural killer (NK) cells [22, 23] and is expressed on invariant natural killer T (NKT) cells and mucosalassociated invariant T (MAIT) cells, which are involved in IBD [7, 9] . Except for this, CD161 is detected in 20% of peripheral T cells [18] , particularly in CD4 + T cells in the lamina propria in human intestine [20] , where a more frequent population exists in the lamina propria than MAIT cells in the epithelium [9] . CD4 + CD161 + T cells possess the potential to influence immunoregulatory and proinflammatory functions by producing interleukin (IL)-10 and interferon (IFN)-γ in thymocytes, and IL-17 in Crohn's disease and rheumatoid arthritis [1, 12] . However, the function of these cells is still unresolved especially in UC. In general, IL-10 is defined as an immunoregulatory cytokine that closely downregulates the production of proinflammatory cytokines. Important evidence of the immunoregulatory role of IL-10 was provided by IL-10 knockout mice who developed chronic enterocolitis [14] . On the other hand, over-expression of IL-10 mRNA is revealed paradoxically in the active inflammatory site of UC [2, 17] .
By these previous results, we hypothesized that the population of CD4 + CD161 + T cells and IL-10 production may affect the intestinal inflammation in patients with IBD, although the functional role of IL-10 was still controversial as far as its association with immune responses in IBD was concerned. Therefore, in the present study, we investigated the expression and population of CD4 
II. Materials and Methods

Patients
Patients' demographics and history of drug therapy are summarized in Table 1 . We enrolled 83 patients with IBD, colorectal carcinoma, and benign conditions who underwent surgery at the Faculty of Medicine, University of Miyazaki Hospital from January 2007 to December 2008. Patients suffering from UC were judged by clinical and endoscopic symptoms according to the Ulcerative Colitis Disease Activity Index (UCDAI) [25] and remission was defined as UCDAI score 0 or 1, with maximum score in severe disease was 12. The disease status of patients with Crohn's disease was estimated using the Crohn's Disease Activity Index (CDAI) [8] and remission was defined as CDAI ≤150, with active disease defined as >150.
The study protocol was reviewed and approved by the Ethics Committee of Miyazaki University (authorization number 2006-271) and conforms to the provisions of the World Medical Association's Declaration of Helsinki in 1995 (as revised in Tokyo 2004). Informed consent was obtained from all patients before their entry into this study.
Preparation of lamina propria mononuclear cells
Lamina propria mononuclear cells (LPMCs) were isolated from macroscopically inflamed and noninflamed mucosa of freshly obtained surgical specimens from patients with IBD. More than one part of the specimen was taken to investigate the active inflammatory site and inactive inflammatory site. All specimens were taken from resected colonic material from patients with UC and Crohn's disease. The grade of inflammation was estimated at this time using hematoxylin and eosin staining. Grossly normal tissue was taken at least 5 cm proximal to or distal from any macroscopically detectable lesions from control patients according to the method of Fuss et al. [5] . LPMCs were isolated using a modification of the method of Bull and Bookman [4] . Briefly, mucosal strips were washed in Hanks' balanced salt solution without calcium and magnesium (HBSS-CMF, Life Technologies, Japan Ltd.) containing 1 mmol/L of dithiothreitol for 30 min at room temperature to remove mucus. The epithelium was removed using sequential washes in HBSS-CMF containing 1 mM EDTA, and the mucosal strips were incubated for 8 hr at 37°C in HBSS-CMF containing 0.2 mg/mL purified type 3 collagenase (Worthington Biochemical Corp., Freehold, NJ, USA), 0.2 mg/mL deoxyribonuclease I (Worthington Biochemical), 250 U/mL penicillin, 250 μg/mL streptomycin, Although the number of samples between all resected specimens and measurement for the flow-cytometric analysis were not matched, LPMCs were investigated by flow cytometry only when they were obtained in sufficient cell numbers from the specimen to investigate. Otherwise, LPMCs were investigated only by real-time PCR analysis.
Flow cytometric analysis
LPMCs were analyzed using three-color flow cytometry methods according to the protocol published by Ikeda et al. [10] . Briefly, freshly isolated cells (1 × 10 6 cells/mL) were incubated for 30 min on ice with the antibodies, washed with PBS, and then analyzed using a BD FACSCalibur system with CellQuest software (Becton Dickinson, San Jose, CA, USA). Antibodies were used as follows: fluorescein isothiocyanate (FITC)-labeled anti-CD4 (clone RPA-T4) and phycoerythrin (PE)-labeled anti-CD3 (clone UCHT1) were purchased from Bay Bioscience Co., Ltd. Allophycocyanin (APC)-labeled anti-CD161 (clone DX12) was purchased from Becton Dickinson.
RNA isolation and Real-time PCR analysis
LPMCs were diluted in RLT lysis buffer (included in the RNeasy Plus Mini Kit (Qiagen, Hilden, Germany)) containing 1% β-mercaptoethanol and stored at −80°C before RNA isolation. Total RNA was extracted using the RNeasy Plus Mini Kit. Five hundred micrograms of RNA was reverse transcribed using the ReverTra-Ace cDNA synthesis Kit (Toyobo, Osaka, Japan) at 25°C for 10 min and then at 37°C for 120 min with an iCycler (Bio-Rad, Hercules, CA, USA). The cDNA (diluted 1:50) was amplified using probe and primer sets of TaqMan Gene Expression Assays (Life Technologies). TaqMan Universal PCR Master Mix, No AmpErase UNG Kit was used with the primers as follows: IL-10, Hs00174086_m1; ACTB (encoding β-actin), Hs99999903_m1. Using an ABI Prism 7000 system (Life Technologies), amplification was performed for 50 cycles, including denaturation at 95°C for 15 s and primer annealing and extension at 60°C for 1 min. A specific RNA-copy standard was prepared from peripheral blood mononuclear cells treated with anti-CD3 monoclonal antibody (clone UCHT 1) and anti-CD28 monoclonal antibody (clone CD28.2) stimulation (eBioscience, San Diego, CA, USA) for 48 hr. Assays were performed in triplicate. Results are expressed as cytokine mRNA copies per ACTB unit to estimate the average IL-10 mRNA content.
Immunohistochemistry
Paraffin-embedded tissues were cut into 4 μm-thick sections. The sections were deparaffinized with toluene and rehydrated through graded ethanol series. To retrieve antigens for anti-KLRB1 (CD161) rabbit polyclonal antibody (Atlas Antibodies, Bromma, Sweden; product number HPA039113), specimens were autoclaved at 120°C for 15 min in 10 mM citrate buffer, pH 6.0 [24] . For anti-CD4 rabbit monoclonal antibody (Abcam, Cambridge, MA, USA; product number ab133616), we used Tris-EDTA (pH 9.0) according to manufacturer's protocol. For anti-IL-10 mouse monoclonal antibody (Santa Cruz Biotechnology, Heidelberg, Germany, product number sc-8438), we used microwave at 95°C for 10 min in Tris-EDTA (pH 9.0). After inhibition of endogenous peroxidase activity with 3% H 2 O 2 in methanol for 20 min, the sections were preincubated with normal goat serum and 5% BSA in PBS for 1 hr to block non-specific binding of antibodies. Unless otherwise specified, all reactions were conducted at room temperature. The sections were reacted primarily with 0.56 μg/ml of anti-CD4 rabbit monoclonal antibody, 8 μg/ml of anti-IL-10 mouse monoclonal antibody, and 10 μg/ml of anti-CD161 rabbit polyclonal antibody overnight, respectively. Following this, they were reacted with HRP-goat anti-rabbit IgG or HRP-goat anti-mouse IgG for 1 hr. The HRP sites were visualized with 3-amino-9-ethylcarbazole (AEC) or 3,3'-diaminobenzidine (DAB) and counterstained with hematoxylin [19] . As a negative control, normal mouse or rabbit IgG was used at the same concentration instead of the primary antibodies in every experiment.
Statistical analysis
Nonparametric statistics were applied. The MannWhitney rank sum test was used to detect differences between unpaired groups. Correlation was tested with Spearman's rank correlation coefficient. P < 0.05 was considered significant. Analyses were performed using GraphPad Prism 5.0 (MDF Co., Ltd., Japan). (Fig. 1B) . A significant difference was found between patients with active and inactive UC (24.9 ± 10.4%) but not for patients with active or inactive Crohn's disease (14.6 ± 8.99%). In contrast, analysis of CD4 + CD161 − T cells revealed no significant difference between active UC (53.0 ± 10.7%), inactive UC (40.8 ± 12.5%) and control (45.6 ± 9.43%) (Fig. 1C) . Moreover, there was no significant difference in the population analysis of peripheral blood mononuclear cells of the two classes of patients (data not shown). + T cell. Columns represent averages, and error bars represent standard deviation. Mann-Whitney rank sum test was applied. *P < 0.05, **P = not significant. (Fig. 2A) . In contrast, there was no significant correlation between the population of CD4 + CD161 + T cell and CDAI (r = −0.5836, P = 0.0775) (Fig. 2B) .
III. Results
Population of CD4
Expression of CD4, CD161 and IL-10 in active and inactive UC
Representative figures of H&E stain and immunohistochemistry were made from the specimen of active and inactive UC from a patient with UCDAI score 2 ( Fig. 3A-H) . CD161 positive cells were fewer in the specimen from the patients with higher UCDAI score compared with the patients with lower UCDAI score (data not shown).
Immunohistochemical staining in the colonic mucosa + T Cells in IBD of active UC revealed that the CD4 positive cells were abundant in lymphoid aggregates in lamina propria beneath the ulcerated epithelium (Fig. 3C ). Several CD161 positive cells were detected in the area of lymphoid aggregates (Fig.  3E ). IL-10 positive cells were scattered in inflammatory infiltrates in lamina propria, parenchyma and ulceration sites (Fig. 3G) . In inactive UC, CD4 positive cells were extensively detected beneath the non-ulcerated epithelium (Fig. 3D) . Interestingly, higher frequency of CD161 positive cells were detected in inactive UC compared with active UC (Fig. 3F) . IL-10 weakly positive cells were slightly detected in colonic mucosa of inactive UC patients by immunohistochemistry (Fig. 3H) .
Over-expression of IL-10 mRNA in both LPMCs and LP-CD4
+ T cells
We next investigated expression of IL-10 mRNA in the LPMCs. The level of expression of IL-10 mRNA in LPMCs isolated from patients with active UC or active Crohn's disease was significantly higher compared with those of patients with inactive UC, inactive Crohn's disease, or controls (Fig. 4A ). Subsequently, the expression level of IL-10 mRNA in lamina propria (LP)-CD4 + T cells was significantly higher in patients with UC compared with controls (Fig. 4B) .
IV. Discussion
In the present study, we found that the expression and population of CD4 + CD161 + T cells was decreased significantly in inflamed lesions on the colonic mucosa of patients with IBD and that the population of these cells inversely correlated with disease activity in patients with UC. Overexpression of IL-10 mRNA and increased IL-10 production was revealed in active UC.
CD161 is a human cell differentiation molecule firstly defined in mouse as NK 1.1 molecule expressed in invariant NKT cells [15] . Recently it was reported that, while CD161 is expressed by MAIT cells in healthy controls and IBD patients and is mainly detected in the peripheral blood, as well as scattered in the crypts of intestinal epithelium where it plays important roles in gut mucosal immunity by secreting cytokines in IBD patients, it was found no significant relationship with regard to the clinical activity of IBD [9] . In contrast, we investigated the population of CD4 In contrast, an unexpected finding was that gross and microscopic findings were different between active and inactive Crohn's disease, whereas the population of CD4 + CD161 + T cells and IL-10 production did not differ. This population data in Crohn's disease are consistent with that of Kleinschek et al. [12] who reported that Th17 cells expressing CD161. This finding may explain the differences in clinical features between UC and Crohn's disease, indicating that Crohn's disease is a systemic disease with the potential for relapse in the entire gut.
While the reason of depletion of CD4 + CD161 + T cells in active IBD remains unclear, several mechanisms might be involved, such as the expression of proapoptotic features activated by chronic inflammation [9] and the loss of surface markers by bacterial infection [27] . In fact, increased frequency of these cells was reported in the synovial fluid of the patients with rheumatoid arthritis [18] and in the tumor and malignant effusion of breast cancer [11] , in which the local environment is germ-free. We believe further studies are needed to determine whether the populations of these cells are altered in the intestinal bacterial flora.
IL-10 is defined as an anti-inflammatory cytokine that downregulates the production of proinflammatory cytokines and T helper 1 cytokines in general. The data on IL-10 deficient mice by Kuhn et al. showing chronic noninfectious intestinal inflammation exhibited immunoregulatory role of IL-10 [14] . The inhibitory function of secreting Real-time PCR analysis of IL-10 mRNA expression by LPMCs. LPMCs were derived from active UC (n = 14), inactive UC (n = 7), active Crohn's disease (n = 9), inactive Crohn's disease (n = 6), and controls (n = 16) (A). LP-CD4 + T cells were derived from LPMCs of active UC (UC (A), n = 9), active Crohn's disease (CD (A), n = 7), and controls (n = 8), respectively (B). The y-axis indicates the relative value in the ratio of the target gene copy number to that of ACTB. Horizontal bars represent median. Mann-Whitney rank sum test was applied. *P < 0.05. **P = not significant. proinflammatory cytokines, such as IL-6, IFN-γ and tumor necrosis factor-α, by IL-10 was reported in IBD in vitro [6, 13] . On the contrary, Melgar et al. reported the overexpression of IL-10 mRNA in mucosal T cells in active UC [17] . We also demonstrated high expression of IL-10 mRNA of LPMCs and LP-CD4 + T cells in UC. A comparative analysis of IL-10 mRNA from the intestinal mucosa with diverticulitis and IBD revealed similar levels of IL-10 production, but IL-1β expression was higher in IBD compared with diverticulitis [2] . Taking these facts into consideration, insufficiency of IL-10 production to regulate proinflammatory cytokine might be involved in the inflammatory site in UC. Otherwise, high-dose of IL-10 may result in the induction of proinflammatory cytokines in Crohn's disease [26] . Therefore, the function of IL-10 might be influenced by local environmental factors and degree of concentration.
We could not detect the CD4 
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